Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
The P/B ratio is N/A as of 2026-10-06T14:25:43.008Z.
Calculation as of: 2026-10-06T14:25:43.008Z.
Quote observation: 2026-10-06T14:24:42.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
N/A
Market Cap
$1.46B
PB Ratio
2.81
TTM Avg
2.89
3Y Avg
2.18
5Y Avg
2.32
Market Cap
$1.49B
PB Ratio
31.98
TTM Avg
28.42
3Y Avg
18.17
5Y Avg
13.48
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | $1.43B | N/A | N/A | N/A | N/A |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | 2.81 | 2.89 | 2.18 | 2.32 |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.45B | 3.21 | 4.41 | 3.86 | 3.86 |
| GH Research PLC (GHRS)vs › | $1.48B | 4.12 | 4.16 | 2.99 | 2.81 |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.49B | 31.98 | 28.42 | 18.17 | 13.48 |
| AnaptysBio, Inc. (ANAB)vs › | $1.41B | 133.57 | 103.22 | 36.11 | 20.51 |
| Certara, Inc. (CERT)vs › | $1.50B | 1.55 | 1.20 | 1.75 | 2.33 |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.39B | N/A | 42.62 | 34.40 | 31.48 |
| Innoviva, Inc. (INVA)vs › | $1.53B | 1.24 | 1.60 | 1.83 | 2.21 |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.36B | 1.21 | N/A | N/A | N/A |
P/B Ratio
N/A
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
